OverviewChartNewsTraderScreen

Soc. Generale Call 560 LLY 19.06..../  DE000SU55QQ1  /

Frankfurt Zert./SG
2024-05-22  12:05:12 PM Chg.+0.010 Bid1:02:25 PM Ask1:02:25 PM Underlying Strike price Expiration date Option type
3.030EUR +0.33% 3.040
Bid Size: 10,000		 3.060
Ask Size: 10,000		 ELI LILLY 560.00 - 2026-06-19 Call
TeleTrader 05-21 Eli Lilly's diabetes drug receives authorization in China
GlobeNewswire 05-16 BeyondSpring R&D Day Highlights New Plinabulin Development Strategy for Cancer and Updates for SEED ...
GlobeNewswire 05-16 Totus Medicines Announces Strategic Multi-Target Research Collaboration with Lilly
GlobeNewswire 05-16 HEPHAISTOS secures €10.3 M to reach the clinical stage
GlobeNewswire 05-15 Entera Bio Appoints Dr. Rachel B Wagman as Key Clinical Advisor and Scientific Advisory Board Member
GlobeNewswire 05-13 Lycia Therapeutics Completes $106.6 Million Series C Financing to Advance Pipeline of LYTAC Extracel...
GlobeNewswire 05-09 US Neurologists Report Route of Administration as a Critical Factor when Evaluating Future Parkinson...
GlobeNewswire 05-09 Monopar Therapeutics Reports First Quarter 2024 Financial Results and Strategic Focus on its Radioph...
GlobeNewswire 05-09 ProQR Announces First Quarter 2024 Operating and Financial Results
GlobeNewswire 05-08 Merus Announces Financial Results for the First Quarter 2024 and Provides Business Update
GlobeNewswire 05-08 Therini Bio Announces Positive Preclinical Data Supporting the Development of THN391 in Neurodegener...
GlobeNewswire 05-08 IMUNON Appoints Director Dr. Stacy R. Lindborg as President and CEO
GlobeNewswire 05-08 ProQR Announces Preclinical Proof of Concept Data for AX-0810 Axiomer™ RNA Editing Program Targeting...
GlobeNewswire 05-08 Verve Therapeutics Announces Pipeline Progress and Reports First Quarter 2024 Financial Results
GlobeNewswire 05-03 BeyondSpring To Host Virtual R&D Day to Discuss New Plinabulin Development Strategy for Cancer and U...
GlobeNewswire 05-01 H1 Appoints Seasoned Marketing & Technology Executive Karen Walker to Its Board of Directors
GlobeNewswire 04-30 ViaNautis Bio appoints Dr Steven M. Altschuler as Chairman of its Board of Directors
TeleTrader 04-30 Eli Lilly's Q1 revenue surges 26% to $8.8B
GlobeNewswire 04-30 ViaNautis Bio appoints Dr Steven M. Altschuler as Chairman of its Board of Directors
GlobeNewswire 04-29 BeyondSpring Provides Business Update and Reports Year End 2023 Financial Results
GlobeNewswire 04-29 BeyondSpring Files 2023 Annual Report on Form 20-F
GlobeNewswire 04-29 Sermonix Pharmaceuticals Announces ‘Menopause’ Journal Publication of Article on Oral Lasofoxifene’s...
GlobeNewswire 04-26 HUTCHMED Announces Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorecta...
GlobeNewswire 04-25 American Kidney Fund Launches National Kidney Health Equity Media Campaign
GlobeNewswire 04-23 Recludix Pharma Announces the Appointment of Dr. Ajay Nirula, Accomplished Pharma Executive and Immu...